SEC Form 4 · accession 0001127602-15-010108
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin B Silverstein
Officer — EVP & Chief Strategy Officer
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 2, 2015 | A | 3,829 | $0.00 | A | 9,412 | D | |
| Common StockF2 | Mar 3, 2015 | A | 13,493 | $0.00 | A | 22,905 | D | |
| Common StockF3 | Mar 3, 2015 | A | 2,918 | $0.00 | A | 25,823 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F4 | $146.93 | Mar 2, 2015 | A | 16,762 | A | — | Mar 2, 2025 | Common Stock | 16,762 | 16,762 | D |
Explanation of responses
- F1Represents restricted stock units. Restrictions lapse as follows: 1,276 each on 3/2/16 and 3/2/17; and 1,277 on 3/2/18.
- F2Represents performance based restricted stock units. Restrictions lapse as follows: 4,497 on 5/1/15; and 4,498 each on 5/1/16 and 5/1/17.
- F3Represents performance based restricted stock units. Restrictions lapse as follows: 972 on 5/1/15; and 973 each on 5/1/16 and 5/1/17.
- F4The option, representing a right to purchase a total of 16,762 shares, is exercisable in two equal semi-annual installments of 2,793 shares each and four equal semi-annual installments of 2,794 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted.